Fate Therapeutics Reports First Quarter 2020 Financial Results and Highlights Operational Progress

Go back to Fate Therapeutics Reports First Quarter 2020 Financial Results and Highlights Operational Progress
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 1.97 --0 (-0%)
Previous Close $1.97    52 Week High $4.76 
Open $1.97    52 Week Low $1.46 
Day High $1.97    P/E N/A 
Day Low $1.97    EPS $-1.91 
Volume 29,994